ACE Report Cover
Multi-injection HA appears to be more effective than single-injection HA versus saline for knee OA
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Idioma
Download Download Download
Descargar
Cite this Report Cite this Report Cite this Report
Citar
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoritos
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Idioma
Download Download Download
Descargar
Cite this Report Cite this Report Cite this Report
Citar
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoritos
OSTEOARTHRITIS
Multi-injection HA appears to be more effective than single-injection HA versus saline for knee OA .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2018;6(2):8 BMC Musculoskelet Disord. 2017 Dec 21;18(1):542
Autores colaboradores

P Sancheti A Concoff F Niazi P Shaw J Rosen

30 blinded randomized controlled trials evaluating the use of hyaluronic acid injections in comparison to a placebo injection in patients with knee osteoarthritis were included in this systematic review and meta-analysis. The objective of this systematic review and meta-analysis was to compare the efficacy and safety of hyaluronic acid injections across different dosing regimens. At 3 months, data were available for 2-4 injection and 5+ injection groups. The 2-4 injection groups demonstrated significantly lower pain scores compared placebo (SMD -0.76 p<0.00001), while the 5+ injection groups did not demonstrate significantly lower pain compared to placebo (SMD -0.20; p=0.09). At 6 months, both the 2-4 injection group (SMD -0.36; p=0.008) and 5+ injection group demonstrated significantly lower pain compared to placebo (SMD -0.18; p=0.04). The single injection groups did not significantly reduce pain compared to placebo at 6 months (SMD -0.04; p=0.67). When looking at the incidence of adverse events, only the 5+ injection group demonstrated a significantly greater incidence compared to placebo (RR 1.67; p=0.02).


Detalles de la financiación de la publicación +
Financiación:
Industry funded
Patrocinador:
Ferring Pharmaceuticals
Conflictos:
Company Employee

Riesgo de sesgo

10/10

Criterios de información

19/20

Índice de fragilidad

N/A

Were the search methods used to find evidence (original research) on the primary question or questions stated?

Was the search for evidence reasonably comprehensive?

Were the criteria used for deciding which studies to include in the overview reported?

Was the bias in the selection of studies avoided?

Were the criteria used for assessing the validity of the included studies reported?

Was the validity of all of the studies referred to in the text assessed with use of appropriate criteria (either in selecting the studies for inclusion or in analyzing the studies that were cited)?

Were the methods used to combine the findings of the relevant studies (to reach a conclusion) reported?

Were the findings of the relevant studies combined appropriately relative to the primary question that the overview addresses?

Were the conclusions made by the author or authors supported by the data and or analysis reported in the overview?

How would you rate the scientific quality of this evidence?

Sí = 1

Incierto = 0,5

No relevante = 0

No = 0

La evaluación de los criterios de información evalúa la transparencia con la que los autores informan de las características metodológicas y del ensayo dentro de la publicación. La evaluación se divide en cinco categorías que se presentan a continuación.

4/4

Introduction

4/4

Accessing Data

4/4

Analysing Data

3/4

Results

4/4

Discussion

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

El Índice de Fragilidad es una herramienta que ayuda en la interpretación de hallazgos significativos, proporcionando una medida de fuerza para un resultado. El Índice de Fragilidad representa el número de eventos consecutivos que es necesario añadir a un resultado dicotómico para que el hallazgo deje de ser significativo. Un número pequeño representa un hallazgo más débil y un número grande un hallazgo más fuerte.

¿Por qué se necesitaba ahora este estudio?

Injection therapies are a prominent topic in research of knee osteoarthritis treatment. Viscosupplementation with intra-articular injection of hyaluronic acid remains one of the most researched and controversial methods of treatment. There is a debate as to whether the number of HA injections administered significantly influences efficacy.

¿Cuál era la pregunta principal de la investigación?

In the treatment of knee osteoarthritis, is there a significant difference in effect on pain between single injection, 2-4 injection, and 5+ injection protocols when compared to placebo saline?

Características del estudio +
Fuente de datos:
MEDLINE, EMBASE, and PubMed were searched for relevant articles published up to February 26, 2016.
Términos del índice:
Full search strategies for each database can be found in the online appendix of the full publication.
Selección de estudios:
Eligibility criteria included: a randomized controlled trial design; allocation of patients to the administration of either intra-articular hyaluronic acid or intra-articular saline; blinded administration and assessment; reported outcome related to pain; and published in English. Search and selection were performed in duplicate.
Extracción de datos:
Data extraction was performed by one reviewer, and cross-checked for accuracy by a second reviewer.
Síntesis de datos:
Statistical analyses were performed using Review Manager software (RevMan 5.3). Standardized mean differences were calculated for continuous outcomes (ie. pain), with 95% confidence intervals. Risk ratios were calculated for dichotomous outcomes, with 95% confidence intervals. Analyses were categorized by the number of injections administered, either as 1 injection, 2-4 injections, or 5+ injections.
¿Cuáles fueron los hallazgos importantes?
  • Only data on 2-4 injection and 5+ injection groups were available at 3 months. The 2-4 injection groups demonstrated significantly lower pain scores compared placebo (6 studies; SMD -0.76 [95%CI -0.98, -0.53]; p<0.00001), but 5+ injection groups did not demonstrate significantly lower pain compared to placebo (3 studies; SMD -0.20 [95%CI -0.43, 0.03]; p=0.09).
  • At 6 months, 2-4 injection groups (10 studies; SMD -0.36 [95%CI -0.63, -0.09]; p=0.008) and 5+ injection groups demonstrated significantly lower pain compared to placebo (6 studies; SMD -0.18 [95%CI -0.35, -0.01]; p=0.04); single injection groups did not significantly differ in pain scores to placebo (2 studies; SMD -0.04 [95%CI -0.20, 0.13]; p=0.67).
  • The incidence of adverse events did not significantly differ between 1 injection groups and placebo (4 studies; RR 1.22 [95%CI 0.85, 1.75]; p=0.28), and 2-4 injection groups and placebo (4 studies; RR 0.97 [95%CI 0.86, 1.08]; p=0.57); 5+ injection groups demonstrated a significantly higher incidence of adverse events compared to placebo (5 studies; RR 1.67 [95%CI 1.09, 2.56]; p=0.02).
¿Qué es lo que más debo recordar?

In knee osteoarthritis treatment, two to four IA HA injections demonstrated effective pain reduction compared to placebo at 3 and 6 months, without a significant increase in the rate of adverse events. Single IA HA injection did not reduce pain compared to placebo after 6 months, and while five or more IA HA injections demonstrated significant pain reduction compared to placebo at 6 months, they were also associated with a significantly greater incidence of adverse events.

¿Cómo afectará esto al cuidado de mis pacientes?

The results of this study suggest that, currently, the most optimal IA HA injection protocol for knee osteoarthritis is 2-4 injections, given the balance between both efficacy and safety measures. Nonetheless, direct comparisons are required between different numbers of injections, as well as on subgroups of particular IA HA product characteristics, such as molecular weight and crosslinking.

DESCARGO DE RESPONSABILIDAD

El contenido de esta página tiene únicamente fines informativos y no pretende sustituir el consejo, diagnóstico o tratamiento médico profesional. Si necesita tratamiento médico, busque siempre el consejo de su médico o acuda al servicio de urgencias más cercano. Las opiniones, creencias y puntos de vista expresados por las personas sobre el contenido que se encuentra en esta página no reflejan las opiniones, creencias y puntos de vista de OrthoEvidence.

0 de 4 artículos mensuales GRATIS desbloqueados
Ha alcanzado su límite de vistas de 4 artículos gratuitos este mes

Acceda a OrtoEvidencia por tan sólo 1,99 $ a la semana.

Manténgase conectado con las últimas pruebas. Cancele en cualquier momento.
  • Valoraciones críticas de los últimos ensayos controlados aleatorizados de gran impacto y revisiones sistemáticas en ortopedia
  • Acceso al contenido del podcast OrthoEvidence, que incluye colaboraciones con el Journal of Bone and Joint Surgery, entrevistas con cirujanos reconocidos internacionalmente y mesas redondas sobre noticias y temas ortopédicos
  • Suscripción a The Pulse, un boletín quincenal basado en la evidencia y diseñado para ayudarle a tomar mejores decisiones clínicas
Upgrade
Close Dialog
Bienvenido
¿Ha olvidado su contraseña?
Comience hoy mismo su prueba GRATUITA

Su cuenta estará afiliada a
e incluye acceso gratuito a OrthoEvidence


O
¿Olvidó su contraseña?

O
Compruebe su correo electrónico

Si existe una cuenta con la dirección de correo electrónico proporcionada, se le enviará un correo electrónico para restablecer la contraseña. Si no ve el correo electrónico, compruebe su carpeta de correo no deseado o spam.

Si necesita más ayuda póngase en contacto con nuestro equipo de asistencia.

Inicie sesión para activar esta función

Para acceder a esta función, debe iniciar sesión en una cuenta activa de OrthoEvidence. Por favor, inicie sesión o cree una cuenta de prueba GRATUITA.

Traducir Informe ACE

OrthoEvidence utiliza un servicio de traducción de terceros para que el contenido sea accesible en varios idiomas. Tenga en cuenta que, aunque se hace todo lo posible para garantizar la exactitud, las traducciones no siempre son perfectas.

Cómo citar esto ACE Report

OrthoEvidence. Multi-injection HA appears to be more effective than single-injection HA versus saline for knee OA. OE Journal. 2018;6(2):8. Available from: https://myorthoevidence.com/AceReport/Show/multi-injection-ha-appears-to-be-more-effective-than-single-injection-ha-versus-saline-for-knee-oa

Copiar cita
Inicie sesión para activar esta función

Para acceder a esta función, debe iniciar sesión en una cuenta activa de OrthoEvidence. Por favor, inicie sesión o cree una cuenta de prueba GRATUITA.

Función de miembro Premium

Para acceder a esta función, debe iniciar sesión en una cuenta Premium de OrthoEvidence.

Compartir ACE Report